Journal
CURRENT DIABETES REPORTS
Volume 12, Issue 3, Pages 314-323Publisher
CURRENT MEDICINE GROUP
DOI: 10.1007/s11892-012-0271-x
Keywords
Cerebrovascular disorders; Stroke; Cerebral hemorrhage; Ischemic attack; Transient; Diabetes mellitus; Diagnosis; Therapeutics; Cerebrovascular disease
Categories
Funding
- Takeda Pharmaceuticals North America
Ask authors/readers for more resources
Cerebrovascular disease is a leading cause of morbidity and mortality in diabetes. Compared with nondiabetic patients, diabetic patients have at least twice the risk for stroke, earlier onset of symptoms, and worse functional outcomes. Approximately 20 % of diabetic patients will die from stroke, making it one of the leading causes of death in this population. Effective strategies for primary and secondary prevention of stroke have been developed in research cohorts that included both diabetic and nondiabetic patients. Nevertheless, prevention in diabetes has some specific considerations. In this paper, we summarize evidence to guide the diagnosis and management of stroke in diabetic patients. We propose that diabetic stroke patients should have a robust risk assessment to target interventions, like other patients with cerebrovascular disease, but with special attention to glycemic control and lifestyle modification.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available